Altre lingue IRADIMED CORPORATION

Azioni

IRMD

US46266A1097

Tempo differito Nasdaq Altri mercati azionari 19:00:00 03/07/2024			Variaz. 5gg	Var. 1 gen.
43,98 ^USD	+0,71%		+2,16%	-7,35%

02/05	Transcript : IRADIMED CORPORATION, Q1 2024 Earnings Call, May 02, 2024
02/05	IRADIMED CORPORATION riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

IRadimed to Begin Trading on the Nasdaq Global Market	07/06
IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market	07/06
IRADIMED : AMENDMENT TO SUSI, LLC LEASE AGREEMENT - Form 8-K	03/06
Earnings Flash (IRMD) IRADIMED CORPORATION Posts Q1 Revenue $17.6M	02/05
Earnings Flash (IRMD) IRADIMED CORPORATION Reports Q1 EPS $0.36	02/05
IRadimed: Q1 Earnings Snapshot	02/05
IRADIMED CORPORATION Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05
IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share	02/05
IRADIMED CORPORATION Declares Regular Quarterly Cash Dividend, Payable on May 30, 2024	02/05
IRADIMED CORPORATION Provides Revenue Guidance for the Second Quarter of 2024; Reiterates Earnings Guidance for the Full Year of 2024	02/05
IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd	25/04
IRadimed Files $75 Million Common Stock Shelf Registration	03/04
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference	13/03
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference	13/03
IRadimed: Q4 Earnings Snapshot	08/02
Earnings Flash (IRMD) IRADIMED CORPORATION Posts Q4 Revenue $17.5M	08/02
Earnings Flash (IRMD) IRADIMED CORPORATION Reports Q4 EPS $0.39	08/02
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results	08/02
IRadimed Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	08/02
IRadimed Corporation Provides Revenue Guidance for the First Quarter and Full Year of 2024	08/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue IRADIMED CORPORATION

Azioni

IRMD

US46266A1097

Altre lingue

Filtri